Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers

Epilepsia

Volumn 50, Issue 6, 2009, Pages 1409-1418

  Toering, Sjoukje T ^b   Boer, Karin ^c   De Groot, Marjolein ^b,c   Troost, Dirk ^c   Heimans, Jan J ^b   Spliet, Wim G M ^d   Van Rijen, Peter C ^d   Jansen, Floor E ^e   Gorter, Jan A ^f,g   Reijneveld, Jaap C ^b   Aronica, Eleonora ^a,c,f  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cortex; Cortical dysplasia; Epilepsy; Human; Synaptic vesicle protein; Tuberous sclerosis complex

Indexed keywords

GLYCOPROTEIN; SYNAPTIC VESICLE PROTEIN 2A; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; DENDRITE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTRACTABLE EPILEPSY; MALE; NERVE CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN TRANSPORT; SCHOOL CHILD; SYNAPSE VESICLE; TUBEROUS SCLEROSIS;

ADOLESCENT; ADULT; AUTOPSY; CEREBRAL CORTEX; CHILD; FEMALE; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MEMBRANE GLYCOPROTEINS; NERVE TISSUE PROTEINS; SYNAPTOPHYSIN; TUBEROUS SCLEROSIS; YOUNG ADULT;

EID: 66849099831     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01955.x     Document Type: Article

References (46)

1. Alonso-Nanclares L, Garbelli R, Sola RG, Pastor J, Tassi L, Spreafico R, DeFelipe J 2005) Microanatomy of the dysplastic neocortex from epileptic patients. Brain 128 : 158 173. (Pubitemid 40070530)
2. Aronica E, Leenstra S, van Veelen CW, van Rijen PC, Hulsebos TJ, Tersmette AC, Yankaya B, Troost D 2001) Glioneuronal tumors and medically intractable epilepsy: a clinical study with long-term follow-up of seizure outcome after surgery. Epilepsy Res 43 : 179 191. (Pubitemid 32204444)
3. Aronica E, Boer K, van Vliet EA, Baayen JC, Redeker S, Spliet WGM, Lopes Da Silva FH, Wadman WJ, Troost D, Gorter JA 2007a) Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 26 : 497 511. (Pubitemid 46756320)
4. Aronica E, Redeker S, Boer K, Spliet WG, van Rijen PC, Gorter JA, Troost D 2007b) Inhibitory networks in epilepsy-associated gangliogliomas and in the perilesional epileptic cortex. Epilepsy Res 74 : 33 44. (Pubitemid 46413705)
5. Bajjalieh SM, Frantz GD, Weimann JM, McConnell SK, Scheller RH 1994) Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci 14 : 5223 5235. (Pubitemid 24279045)
6. Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB 2005) A developmental and genetic classification for malformations of cortical development. Neurology 65 : 1873 1887. (Pubitemid 43970104)
7. Bennett B, Matagne A, Michel P, Leonard M, Cornet M, Meeus MA, Toublanc N 2007) Seletracetam (UCB 44212). Neurotherapeutics 4 : 117 122.
8. Cepeda C, Hurst RS, Flores-Hernandez J, Hernandez-Echeagaray E, Klapstein GJ, Boylan MK, Calvert CR, Jocoy EL, Nguyen OK, Andre VM, Vinters HV, Ariano MA, Levine MS, Mathern GW 2003) Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 72 : 472 486. (Pubitemid 36523422)
9. Cepeda C, Andre VM, Vinters HV, Levine MS, Mathern GW 2005) Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia? Epilepsia 46 : 82 88. (Pubitemid 40962126)
10. Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, Scheller RH, Chavkin C, Bajjalieh SM 1999) Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U S A 96 : 15268 15273. (Pubitemid 30019801)
11. Custer KL, Austin NS, Sullivan JM, Bajjalieh SM 2006) Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J Neurosci 26 : 1303 1313. (Pubitemid 43237062)
12. D'Agostino MD, Bastos A, Piras C, Bernasconi A, Grisar T, Tsur VG, Snipes J, Juhasz C, Chugani H, Guerrini R, Cross H, Andermann E, Dubeau F, Montes J, Olivier A, Andermann F 2004) Posterior quadrantic dysplasia or hemi-hemimegalencephaly: a characteristic brain malformation. Neurology 62 : 2214 2220. (Pubitemid 38787778)
13. DiMario FJ Jr. 2004) Brain abnormalities in tuberous sclerosis complex. J Child Neurol 19 : 650 657.
14. Engel JJ 1993) Outcome with respect to epileptic seizures. In Engel JJ (Ed) Surgical treatment of the epilepsies. Raven Press, New York, pp. 609 621.
15. Fauser S, Huppertz HJ, Bast T, Strobl K, Pantazis G, Altenmueller DM, Feil B, Rona S, Kurth C, Rating D, Korinthenberg R, Steinhoff BJ, Volk B, Schulze-Bonhage A 2006) Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain 129 : 1907 1916. (Pubitemid 43999421)
16. Friedman D, French JA 2006) Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures. Neurology 66 : 590 591. (Pubitemid 43739896)
17. Gillard M, Chatelain P, Fuks B 2006) Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. Eur J Pharmacol 536 : 102 108.
18. Glien M, Brandt C, Potschka H, Loscher W 2002) Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Epilepsia 43 : 350 357. (Pubitemid 34297172)
19. Gomez M, Sampson J, Whittemore V 1999) The tuberous sclerosis complex. Oxford University Press, Oxford.
20. Gorter JA, Van Vliet E, Aronica E, Rauwerda H, Breit T, Lopes Da Silva FH, Wadman WJ 2006) Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci 26 : 11083 11110. (Pubitemid 44772198)
21. Janz R, Sudhof TC 1999) SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family. Neuroscience 94 : 1279 1290. (Pubitemid 29509692)
22. Janz R, Goda Y, Geppert M, Missler M, Sudhof TC 1999) SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron 24 : 1003 1016. (Pubitemid 30017678)
23. Lippa CF, Pearson D, Smith TW 1993) Cortical tubers demonstrate reduced immunoreactivity for synapsin I. Acta Neuropathol 85 : 449 451. (Pubitemid 23100937)
24. Loscher W, Schmidt D 2006) Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs. Epilepsia 47 : 1253 1284. (Pubitemid 44200405)
25. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B 2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 101 : 9861 9866. (Pubitemid 38869327)
26. Mathern GW, Giza CC, Yudovin S, Vinters HV, Peacock WJ, Shewmon DA, Shields WD 1999) Postoperative seizure control and antiepileptic drug use in pediatric epilepsy surgery patients: the UCLA experience, 1986-1997. Epilepsia 40 : 1740 1749.
27. Meldrum BS, Rogawski MA 2007) Molecular targets for antiepileptic drug development. Neurotherapeutics 4 : 18 61. (Pubitemid 46107329)
28. Mizuguchi M, Takashima S 2001) Neuropathology of tuberous sclerosis. Brain Dev 23 : 508 515. (Pubitemid 32999117)
29. Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, Jackson G, Luders HO, Prayson R, Spreafico R, Vinters HV 2004) Terminology and classification of the cortical dysplasias. Neurology 62 : S2 S8.
30. Quinn B 1998) Synaptophysin staining in normal brain: importance for diagnosis of ganglioglioma. Am J Surg Pathol 22 : 550 556. (Pubitemid 28213741)
31. Quinn B 1999) Synaptophysin staining for ganglioglioma [comment]. AJNR Am J Neuroradiol 20 : 526 529.
32. Ravizza T, Boer K, Redeker S, Spliet WG, van Rijen PC, Troost D, Vezzani A, Aronica E 2006) The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 24 : 128 143. (Pubitemid 44416213)
33. von Rosenstiel P 2007) Brivaracetam (UCB 34714). Neurotherapeutics 4 : 84 87.
34. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC 1985) Measurement of protein using bicinchoninic acid [published erratum appears in Anal Biochem 1987 May 15;163(1):279]. Anal Biochem 150 : 76 85. (Pubitemid 16258399)
35. Smith TW, Nikulasson S, De Girolami U, De Gennaro LJ 1993) Immunohistochemistry of synapsin I and synaptophysin in human nervous system and neuroendocrine tumors. Applications in diagnostic neuro-oncology. Clin Neuropathol 12 : 335 342. (Pubitemid 23361933)
36. Thom M 2004) Recent advances in the neuropathology of focal lesions in epilepsy. Expert Rev Neurother 4 : 973 984. (Pubitemid 39482270)
37. van Veelen CW, Debets RM, van Huffelen AC, van Emde Boas W, Binnie CD, Storm van Leeuwen W, Velis DN, van Dieren A 1990) Combined use of subdural and intracerebral electrodes in preoperative evaluation of epilepsy. Neurosurgery 26 : 93 101. (Pubitemid 20209545)
38. van Vliet EA, Van Schaik R, Edelbroek PM, Lopes Da Silva FH, Wadman WJ, Gorter JA 2008) Development of tolerance to levetiracetam in rats with chronic epilepsy. Epilepsia 49 : 1151 1159.
39. van Vliet EA, Aronica E, Redeker S, Boer K, Gorter JA 2008) Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia [Epub ahead of print].
40. Vinters HV 2002) Histopathology of brain tissue from patients with infantile spasms. Int Rev Neurobiol 49 : 63 76.
41. Vinters HV, Fisher RS, Cornford ME, Mah V, Secor DL, De Rosa MJ, Comair YG, Peacock WJ, Shields WD 1992) Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue. Childs Nerv Syst 8 : 8 17.
42. Wieser HG 2004) ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 45 : 695 714.
43. Wong M 2008) Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 49 : 8 21.
44. Yamanouchi H, Ho M, Jay V, Becker LE 1997) Giant cells in cortical tubers in tuberous sclerosis showing synaptophysin-immunoreactive halos. Brain Dev 19 : 21 24. (Pubitemid 27116979)
45. Yasha TC, Santosh V, Das S, Shankar SK 1997) Hemimegalencephaly - morphological and immunocytochemical study. Clin Neuropathol 16 : 17 22. (Pubitemid 27049105)
46. Zhang PJ, Rosenblum MK 1996) Synaptophysin expression in the human spinal cord. Diagnostic implications of an immunohistochemical study. Am J Surg Pathol 20 : 273 276. (Pubitemid 26071507)